Back

FLCN-related HCM: A patient with a potential novel truncating variant presenting with septal and apical LV hypertrophy and high-risk for malignant ventricular arrhythmias

9 May 2026 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: Hypertrophic cardiomyopathy: from obstruction to innovation Clinical Delegates Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Raquel Montalvao

Centro Universitario da Unidade Local de Saude de Lisboa Ocidental, Lisboa (Portugal)

4 More presentations in this session

Presentation thumbnail
Integrated surgical management of obstructive hypertrophic cardiomyopathy and heart failure: septal myectomy with mitral valve repair
Doctor C. Angelescu (Bucharest, RO)
Slides Video
Presentation thumbnail
Effects of Mavacamten use in a patient with hypertrophic obstructive cardiomyopathy and extremely high resting left ventricular outflow tract gradient
Doctor E. Wang (Singapore, SG)
Slides Video
Presentation thumbnail
Hypertrophic cardiomyopathy at the diagnostic threshold of Gaucher disease
Doctor M. Malek-Elikowska (Poznan, PL)
Slides Video
Presentation thumbnail
When calcification meets motion: mitral annular calcification and systolic anterior motion of the mitral valve driving heart failure in HOCM
Doctor C. Angelescu (Bucharest, RO)
Slides Video

Access the full session

Session thumbnail
Hypertrophic cardiomyopathy: from obstruction to innovation
Video

The Event

Event poster

Heart Failure 2026

9 May - 12 May 2026
You may be interested in
thumbnail
Congress Session
Heartfelt genetics
thumbnail
Congress Session
Hypertrophic cardiomyopathy: from obstruction to innovation
thumbnail
Congress Session
Monogenetic cardiac diseases

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources